Stockreport

BiondVax Announces Second Quarter 2018 Financial Results

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors
PDF JERUSALEM, Aug. 22, 2018 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and comme [Read more]